Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?: Difference between revisions
mNo edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
Webpage shortcut: '''[http://goo.gl/xszDH goo.gl/xszDH]''' | Webpage shortcut: '''[http://goo.gl/xszDH goo.gl/xszDH]''' | ||
<br /><br /> | <br /><br /> | ||
'''Online Registration'''<br /><br /> | '''[https://docs.google.com/spreadsheet/viewform?formkey=dFhiejdvN0RuekNkai1IV0ZsVTBfMGc6MQ Online Registration]'''<br /><br /> | ||
'''Resource Person'''<br /> | '''Resource Person'''<br /> | ||
Revision as of 22:24, 26 October 2012
An ELSI Colloquium on "Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?"
10 December 2012 (Monday), 2pm
Buenafe Hall
College of Medicine
University of the Philippines - Manila
Webpage shortcut: goo.gl/xszDH
Online Registration
Resource Person
Dr Reidar K. Lie
Adjunct Research Fellow
Department of Bioethics
Clinical Center
National Institutes of Health, USA
See Also
“Ethical, Legal, Social Issues” (ELSI) Program, Philippine Genome Center